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Prion Protein and the Transmissible Minireview
Spongiform Encephalopathy Diseases
surface protein in a variety of tissues and cell types both
within and outside the nervous system (Caughey and
Chesebro, 1997). The main difference between PrP-res
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and PrP-sen appears to be in their folded structures.National Institute of Allergy and Infectious Diseases
The structure for PrP-sen has recently been solved byNational Institutes of Health
NMR and has an N-terminal flexible domain followed byHamilton, Montana 59840
a C-terminal globular domain with three a helices (Riek
et al., 1996). In contrast, the precise structure of PrP-res
is not known, but biophysical measurements indicate aTransmissible spongiform encephalopathy (TSE) dis-
high amount of b sheet structure. Furthermore, PrP-reseases or prion diseases are rare fatal neurodegenerative
often forms fibrils that show birefringence after bindingdiseases of humans and other animals. In the past de-
of Congo red. This property is a well-known characteris-cade, a high awareness of TSE diseases has developed
tic of b sheet±rich non-PrP amyloid proteins found indue to the appearance of bovine spongiform encepha-
amyloidosis associated with other diseases, such aslopathy (BSE) or ªmad cow diseaseº in the United King-
type II diabetes, Alzheimer's disease, tuberculosis, rheu-dom. Due to the potential for human infection, in Europe
matoid arthritis, and various cancers.BSE has influenced medical, agricultural, economic, and
The generation of PrP-res from PrP-sen has beenpolitical issues, perhaps even to a greater extent than
studied in scrapie-infected mouse cells as well as underhas AIDS.
cell-free conditions in test tubes (Caughey and Chese-Primary symptoms of TSE diseases in humans are
bro, 1997). The PrP-res generated in these cell-free labo-dementia and ataxia. These diseases are usually charac-
ratory studies mimics closely the material produced interized by spongiform degeneration of the brain ac-
brains of scrapie-infected animals and humans. How-companied by appearance of activated astrocytes and
ever, because these cell-free experiments contain largeaccumulation of abnormal aggregates consisting of pro-
amounts of infectivity associated with the PrP-res usedtease-resistant prion protein (PrP), which sometimes
to initiate the conversion process, it has not yet beenforms amyloid-like plaques. TSE diseases are transmis-
possible to prove that the abnormal PrP formed in vitrosible by inoculation or ingestion of infected tissues. In-
is actually infectious.cubation periods prior to clinical symptoms range from
The normal function of PrP-sen is not known. PrP ismonths to years, and in the case of some kuru patients
not essential for viability, as some lines of PrP knockoutmay have been as long as 40 years.
mice are fertile and neurologically normal, althoughTSE diseases in humans can be divided into three
some sleep abnormalities have been observed. Othergroups: sporadic, familial, and iatrogenic (or infectious)
lines of PrP knockout mice have shown cerebellar de-(Brown et al., 1994). Sporadic Creutzfeldt-Jakob disease
generation, but this difference may be due to disruption(CJD) is not associated with any known mutations and
of adjacent genes. Interestingly, expression of PrP-senoccurs world-wide at an incidence of around 1 per 2
is required for susceptibility to TSE diseases, and propa-million. The source of this disease is completely un-
gation of infectivity is eliminated or drastically reducedknown. Familial TSE diseases are all associated with
in the absence of the PrP gene (Weissmann, 1999). Thisdifferent mutations in the PrP gene, and include familial
has been interpreted to imply that PrP is either a receptor
CJD, Gerstmann-StraÈ ussler-Scheinker syndrome (GSS),
for the infectious agent or a component of the agent.
and fatal familial insomnia (FFI). Infectious or iatrogenic Natural and Experimental Scrapie in Sheep
TSE diseases include kuru, which was spread by ritual Scrapie has been recognized as a disease in sheep for
cannibalism in New Guinea tribesmen, CJD, which is over 2 centuries, and was the first TSE disease to be
spread by transplantation or inoculation with brain tis- shown as experimentally transmissible. Thus, sheep
sues or extracts from unsuspected CJD patients, and scrapie provides an unusual opportunity to compare
variant CJD (vCJD), which is apparently due to infection natural and experimental TSE disease processes. Al-
of humans with the agent of BSE. though in animals there are no known genetic cases of
Prion Protein (PrP) TSE disease comparable to those seen in humans, allelic
Besides transmissibility, the other hallmark of TSE dis- variations in the sheep PrP sequence do occur, and
eases is the presence of abnormal protease-resistant variation at several residues in the PrP sequence influ-
PrP (PrP-res, also known as PrPSc), detectable by immu- ences susceptibility to both natural and experimental
noblot or immunohistochemistry in the brains of afflicted scrapie infection. The mechanism of these effects is
individuals. PrP-res is believed to be responsible for the not known, but these data show clearly that PrP is an
pathogenic effects in the TSE diseases, either by direct important susceptibility factor for TSE diseases. A simi-
toxicity or indirect effects due to interactions with the lar effect may also occur in humans, where variation at
normal PrP expressed on many brain cells. PrP-res is PrP codon 129 does not induce a familial TSE disease
generated posttranslationally by an unknown mecha- but instead appears to influence susceptibility to spo-
nism from normal protease-sensitive PrP (PrP-sen, also radic CJD.
known as PrPC), which is expressed as a GPI-linked cell Although the infectious nature of sheep scrapie has
been long recognized, the mode of transmission within
a flock is not clear. Direct physical contact between* E-mail: bchesebro@nih.gov.
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individuals is not required, and there are numerous re- and the host animal. Similar studies extended these
results using scrapie-infected mouse neuroblastomaports of transmission by pasturing sheep on ground
previously occupied by a flock with a high scrapie inci- cells, where differences at PrP amino acid residue 138
were identified as critical for cross-species resistancedence. Such pastures appear to be contaminated by
scrapie infectivity perhaps derived from placental tissue, between mice and hamsters as measured by PrP-res
formation. Interestingly, this residue is homologous tofetal membranes, or decomposing carcasses.
Bovine Spongiform Encephalopathy (BSE) a polymorphic residue at position 142 in goat PrP, which
was previously found to influence resistance to BSE andIn the past decade, the BSE epidemic in the UK has
brought international attention to the TSE family of dis- certain sheep scrapie strains in vivo.
Similar studies have shown that transgenic mice ex-eases (reviewed by Collee and Bradley, 1997). BSE was
spread by feeding of protein supplements contaminated pressing human PrP have increased susceptibility to
many human TSE disease isolates. This has broadenedwith the rendered tissues of BSE-positive cattle. Several
laboratory tests, including PrP-res banding patterns in the possibilities for studying human isolates in less ex-
pensive and more rapid rodent models suitable forprotein gels and comparative titration in various mouse
strains, identify similarities in BSE from all sources screening of possible therapeutic drugs. However, in
spite of extensive knowledge of PrP sequences from atested, as compared to most commonly known isolates
of sheep scrapie. However, it remains unclear whether variety of species, the extent of species-specific resis-
tance to TSE diseases remains impossible to predictBSE originated by adaptation from an unusual strain
of sheep scrapie or from an unrecognized bovine TSE solely by analysis of PrP sequences. This is of critical
importance in the matter of human susceptibility to BSE.case.
BSE has also been transmitted to other species by Transgenic mice expressing PrP using tissue-specific
promoters have been studied to analyze the roles offeeding of contaminated meat and bone meal to ungu-
lates and large felines in zoos and probably also to different PrP-expressing cells on susceptibility to TSE
disease. PrP expression in either neurons or astrocytesdomestic cats. Transmission to humans has also been
suggested by the appearance of vCJD in a small group is sufficient for induction of clinical disease and typical
scrapie neuropathology. This would appear to imply thatof younger humans, primarily in the UK. The similarity
in pathology and in laboratory tests lends support to generation of a toxic PrP-res or peptide moiety in the
brain may be independent of the brain cell type produc-this interpretation. At present, one cannot be certain
whether the vCJD cases represent the beginning of a ing the normal PrP. Testing of mice expressing PrP in
microglia or oligodendroglia will be required to examinemuch larger epidemic in humans or whether they are
unusual cases of transmission across a rather resistant this matter more thoroughly. In contrast to the above
results, PrP expression in liver, T lymphocytes, and Bspecies barrier. In contrast to BSE, there is no evidence
of spread of sheep scrapie to humans. Therefore, there lymphocytes did not induce scrapie susceptibility, sug-
gesting perhaps that the toxic PrP product must bemay be important fundamental differences between
scrapie and BSE in their interactions with different hosts. produced in the brain to have a pathogenic effect.
Routes of NeuroinvasionChronic wasting disease (CWD) in deer and Rocky
Mountain elk in Colorado and Wyoming and transmissi- In mouse scrapie, functional B lymphocytes are neces-
sary for neuroinvasion after infection at peripheral sites,ble mink encephalopathy (TME) on mink ranches are
two other examples of TSE diseases of unknown etiol- but PrP expression on B lymphocytes is not required.
In recent experiments, PrP-negative B lymphocytes mayogy. CWD is now also recognized to be a serious prob-
lem in many ªgame farmsº in other regions of the USA. have influenced neuroinvasion indirectly by allowing the
development of mature spleen follicular dendritic cellsIts spread appears to be enhanced by the abnormal
population densities found in such facilities. (FDCs) as important sites of agent replication and/or
PrP-res accumulation (Klein et al., 1998). Although inExperimental Models
TSE diseases have been studied experimentally in sev- mice replication of scrapie in spleen may be required to
amplify titers after peripheral scrapie infection, spleniceral laboratory species, including mice, rats, hamsters,
and nonhuman primates. In general, TSE diseases show infection was by itself unable to induce transport of
infectivity from spleen to brain. The importance of PrP-a preference for transmission to the species of origin
or a closely related species. Most noteworthy was the positive peripheral nerves in neuroinvasion was recently
demonstrated when transgenic mice expressing PrPoriginal demonstration of the transmissibility of CJD and
kuru from humans to chimpanzees (Gajdusek and Gibbs, only in neurons were shown to develop scrapie after
oral or i.p. infection with high doses of agent (Race et1971). Transmission to a less closely related species
is also possible and appears to involve a progressive al., 2000). Blood-borne transport of infectivity to the
brain remains difficult to exclude completely; however,adaptation during serial passage in the new host.
Early experiments identified the Sinc gene as impor- in most model systems infectivity levels in blood are
extremely low, and transmission by blood transfusiontant in host susceptibility to scrapie (Dickinson et al.,
1968), and subsequently Sinc was found to be the gene in animals has only rarely been effective. Nevertheless,
when considering the issue of blood safety for humanencoding PrP. Experiments with PrP transgenic mice
where expression of hamster PrP was found to render transfusion, it is important to remember that different
animal species and TSE strains might differ in infectivitytransgenic mice susceptible to hamster-specific scrapie
strains also identified PrP as a susceptibility factor for levels of blood.
Transgenic Mouse Models of Familial Human TSEcross-species transmission (Prusiner, 1998). In molecu-
lar studies, the use of chimeric PrP molecules in None of the animal TSE diseases mentioned above serve
as models for the familial forms of human TSE diseases,transgenic mice has identified the importance of amino
acid residues in the central portion of PrP in species- which are strongly associated with different PrP muta-
tions. However, PrP with the mutation from proline tospecific interactions between the inoculated TSE agent
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leucine at position 102, found in human GSS patients, sterilization by heat and chemicals, which led Griffith in
1967 to propose that the agent might be a self-replicat-has been expressed in transgenic mice. More recently,
human PrP with extra amino acid octarepeat regions, ing protein (Griffith, 1967). Following the discovery of
scrapie-associated fibrils (Merz et al., 1981) and thealso associated with familial TSE disease, has been gen-
erated in transgenic mice. For both the Leu-102 PrP identification of PrP as a major component of infectious
fractions, the ªprotein-onlyº hypothesis was refined intomutant and the extra amino acid octarepeat PrP mutant,
mice expressing high amounts of the mutant PrP de- the ªprionº hypothesis (Prusiner, 1982). So far, neither
the viral nor the protein-only model has been proved orvelop a fatal neurological disease with neuropathology
similar but not identical to TSE disease. However, in disproved, and the nature of the infectious agent re-
mains a central mystery in the TSE field (Chesebro,neither model is there generation of abundant PrP-res
with the high degree of protease resistance found in 1998).
Inactivation studies by irradiation, heat, and chemi-the human counterparts of these models. Furthermore,
the transmissibility of the diseases produced in these cals have led to conflicting conclusions regarding the
uniqueness of TSE infectivity. Using heat or hypochlo-mouse models remains questionable. For the octarepeat
mutant, there is no transmission data yet available rite, the majority of infectivity actually shows a kinetics of
inactivation and a small resistant fraction (0.1%±0.01%)(Chiesa et al., 1998). For the Leu-102 mutant, the disease
cannot be transmitted to normal PrP (Pro-102) mice but that is similar to known viral examples, such as bacterio-
phage fd (Rohwer, 1991). This minor resistant fractioncan be transmitted to transgenic mice expressing Leu-
102 PrP at levels too low to induce disease spontane- should not be used to infer unique properties in the
majority of the infectivity.ously (Hsiao et al., 1994). This result has been interpreted
by the authors as evidence for transmission, but it clearly The spectrum for inactivation of scrapie infectivity
by UV irradiation suggested that the critical target wasdoes not mimic the transmission of known TSE diseases
including the human familial Leu-102 PrP disease, which neither protein nor nucleic acid, but instead appeared
to be lipidic in nature (Alper et al., 1978). However, in pastis in fact transmissible to monkeys and mice expressing
only Pro-102 PrP. Thus, in this mouse model the brain virological experiments using nonpenetrating radiation
such as UV, shielding of the critical target molecule ofdisease induced lacks the two critical hallmarks of TSE
disease, PrP-res and transmissibility, and may in fact the infectious agent by other molecules in the mixture
or attached to the agent has been known to influencebe a disease due to overexpression of a mutant protein
rather than a true TSE disease. the results. In fact, the unusual inactivation spectrum
for scrapie was similar to intact tobacco mosaic virus,To avoid artifacts due to abnormal transgene copy
number and abnormal integration sites, PrP with the a well-characterized RNA virus, whereas the isolated
RNA from this virus had peak inactivation at a wave-Pro-102-Leu mutation has been recently substituted
for the normal mouse PrP gene by homologous re- length predicted for a typical nucleic acid. Thus, in view
of these issues and the difficulty in purification of thecombination (Manson et al., 1999). In contrast to the
previous transgenic mice, such recombinant mice fail scrapie agent, UV studies may not provide definitive
information as to the nature of the scrapie infectivity.to develop spontaneous CNS disease. However, they
do have an increased susceptibility to infection by a Scrapie infectivity has also been studied using more
penetrating radiation like X rays, where shielding orhuman GSS isolate. These results suggest that mutant
Pro-102-Leu PrP may be an important susceptibility fac- blocking of the radiation is not an issue. Many experi-
ments have resulted in similar inactivation rate con-tor rather than a direct cause of GSS.
TSE Strains stants; however, different groups have varied markedly
in their interpretation of these results (Rohwer, 1991).The existence of biologically different scrapie strains in
inbred animals with a single type of PrP gene remains Using target theory calculations, some workers have
concluded that the maximum genome size would bean interesting enigma. Disease induced by scrapie
strains can differ in the clinical symptoms produced, the very small. In contrast, others making empirical compar-
isons to viruses with known genomes have arrived atregions of brain affected, and the incubation period prior
to clinical onset. These differences might be explained a genome size consistent with a small (2±4 kb) virus.
However, both of these interpretations might underesti-by mutations in a nucleic acid genome if the infectious
agent is a virus, but no genomes have yet been identi- mate the genome size if the TSE agent had a means of
repairing damaged nucleic acid during replication. Suchfied. In contrast, the existence of strains is difficult to
explain if the infectious agent is a protein. However, a situation occurs with retroviruses, like HIV, in which
the two RNA genomes in each particle can be partiallystructural variations in PrP-res might ªencodeº strain-
specific properties, and recent data suggest that PrP- damaged and then repaired during reverse transcription,
thus giving a higher resistance to x-irradiation than thatres structures might be capable of conferring such prop-
erties on newly formed PrP-res in a template-like predicted by genome size alone.
These data are only indirect evidence that may befashion.
Biophysical Inactivation and the Viral Hypothesis consistent with the viral hypothesis. In spite of many
efforts, there are still no data supporting any candidateIn the past decade, there has been a massive increase
in knowledge concerning many aspects of the TSE dis- viruses. Furthermore, although small nucleic acid mole-
cules have been found in purified infectious scrapieeases largely due to the discovery of PrP. Nevertheless,
there continues to be a paucity of information concern- samples, efforts to identify an intact nucleic acid mole-
cule of potential genome size have met with failure.ing the structure and composition of the infectious
agent. Early ultrafiltration studies suggested that the Therefore, if such a genome exists, it would have to be
capable of regeneration from small fragments by a copyinfectious particle was small and might be a virus.
However, the infectivity showed a strong resistance to choice mechanism during transcription as described
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above. In addition, the role of mutant and nonmutant disease, the protein-only hypothesis has proposed rare
PrP in the case of a viral etiology remains hypothetical. spontaneous misfolding as a possible primary event, but
To explain the very high correlation of TSE disease in presently there is no evidence to support this proposal.
persons with certain PrP mutations, one would have to Misfolded PrP molecules formed by denaturation and
speculate that the mutant PrP might serve as an efficient renaturation in vitro have not generated any infectivity
susceptibility factor or receptor for a viral agent that de novo. Furthermore, in Australia and New Zealand,
might be relatively common in the population. In con- where scrapie has been eradicated, there is no evidence
trast, the normal nonmutant PrP would have to be much of spontaneous recurrence of sheep scrapie. In addition,
less efficient than mutant PrP in this role in order to in humans the peak age incidence of sporadic CJD is
account for the extremely low incidence of sporadic 55±60 years, and if spontaneous misfolding were the
CJD. The recent experiments showing an increased sen- primary event, one might expect a continuously increas-
sitivity to human GSS in mice expressing the Pro-102- ing incidence with age, since more time might allow
Leu mutation might be an example of this situation (Man- more opportunity for rare misfolding events.
son et al., 1999). Similar effects probably occur for many Conclusions
viral diseases in humans where there is a high incidence Research in the past 15 years has provided a wealth
of infection compared to the incidence of clinical dis- of new information on the TSE diseases. Particularly
ease. Examples include HTLV I and B19 parvovirus. noteworthy has been the identification of PrP as a factor
However, at present this possibility remains speculative in disease susceptibility, the species barrier, and many
as applied to TSE diseases in the absence of additional aspects of disease pathogenesis. Further understand-
supportive data using actual candidate viruses. ing of the structure of PrP-res and of amyloids in similar
The Protein-Only Hypothesis diseases, such as Alzheimer's disease, may provide
Although the discovery of PrP has led to a vast increase clues as to the differences and similarities among these
in knowledge concerning the role of PrP in susceptibility protein folding diseases. The problem of the nature of
and pathogenesis of TSE diseases, the question of the TSE agents remains an enigma. Proof of the protein-
whether PrP-res is an integral component of the infec- only hypothesis may require generation of biologically
tious agent remains unresolved. The most important active transmissible agent in a cell-free environment
evidence supporting this concept is the finding that PrP where a virus cannot replicate. Conversely, proof of a
is the predominant macromolecule found in fractions of viral etiology will require identification and isolation of
purified infectious agent. However, two caveats persist a candidate virus. Future efforts should not neglect this
regarding this matter. First, because of the presence of fascinating and important area.
aggregated PrP, the agent is difficult to purify, and the
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